Maximilian Peter Brandt

8PUBLICATIONS
11CO-AUTHORS
Traditional Chinese medicine and treatmentsCancer cell biologyPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 13, 2026
Correction: Zhao et al. Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins. Cells 2025, 14, 570.

|Sep 17, 2025
A Rare Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder in a Young Woman.

Pavlo Synoverskyy, Sameh Hijazi, Thomas Krüer

|Apr 25, 2025
Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins.

Olesya Vakhrusheva, Fuguang Zhao, Sascha Dennis Markowitsch

|Sep 28, 2023
Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma-Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic Segmentation.

Gregor Duwe, Lukas Müller, Christian Ruckes

|Dec 02, 2021
Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer.

Maximilian Peter Brandt, C Ruf, K P Dieckmann

|Jul 17, 2019
Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014.

M P Brandt, K M Gust, D Bon

Pageof 2

Frequent Collaborators

3 joint publications

Igor Tsaur

2 joint publications

Thomas Efferth

2 joint publications

Roman Alexander Blaheta

2 joint publications

Eva Juengel